Neurocrine Biosciences (NBIX) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $139.99 -1.59%
EPS Growth %: -12.4%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -12.4%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
